Chekhonin VP, et al
. Monoclonal anti-GFAP antibodies: extraction, characteristics, and immunoenzyme assay. Bull Exp. Biol. Med. Aug 2001; 132(2): 772-775.
Poletaev AB, et al
. Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders. Autoimmunity. 2000; 32(1): 33-38.
Mecocci P, et al
. Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. J. Neuroimmunol. Mar 1995; 57(1-2): 165-170.
Vacca V.,et al.
Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and Î¼ opioid receptor expression in neuropathic mice.Brain Behav Immun.2013
Marinelli S.,et al.
The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes.PLoS One.2012
You can visit "Citations Database
" for more citations.